Promising results shown for kidney cancer drug
Thursday, February 4, 2010 - 09:21
in Health & Medicine
The drug pazopanib (Votrient) slowed the progression of advanced renal cell carcinoma (RCC), a form of kidney cancer, in patients by 54% percent, according to a new study published in the Journal of...